• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A follow-up study of bone marrow chromosomes and in vitro colony growth in patients with mastocytosis.

作者信息

Swolin B, Rödjer S, al-Obaidy A, Jonell R, Roupe G

机构信息

Department of Clinical Chemistry, Sahlgren's Hospital, Gothenburg, Sweden.

出版信息

Acta Derm Venereol. 1994 May;74(3):163-7. doi: 10.2340/0001555574163167.

DOI:10.2340/0001555574163167
PMID:7915453
Abstract

Proliferation of mast cells can give rise to many clinical manifestations in patients, and an association with hematological disorders has been pointed out. The study was initiated to determine whether patients with mastocytosis show a clinical progression in relation to bone marrow cell parameters analyzed. During a median follow-up period of 5.5 years, 10 patients with mastocytosis were re-examined with regard to clinical symptoms, urine histamine metabolites (U-MeImAA), bone marrow cells examined with chromosome analyses, and in vitro stem cell growth for CFU-GM. Seven patients showed a clinical progression with increase of either symptoms, bone marrow infiltrates of mast cells or U-MeImAA. One patient with a myeloproliferative bone marrow morphology had a malignant course. Four of the 7 patients showed an increased colony growth, while 3 showed a decreased growth, in the second examination compared with the first examination. One patient had a persistent clone with the chromosome aberration 9p+. A variable pattern was observed in the other patients, in resemblance with findings in chronic myeloproliferative disorders. Our conclusion is that mastocytosis belongs to the myeloproliferative disorders.

摘要

相似文献

1
A follow-up study of bone marrow chromosomes and in vitro colony growth in patients with mastocytosis.
Acta Derm Venereol. 1994 May;74(3):163-7. doi: 10.2340/0001555574163167.
2
Cytogenetic studies and in vitro colony growth in patients with mastocytosis.肥大细胞增多症患者的细胞遗传学研究及体外集落生长
Blood. 1987 Dec;70(6):1928-32.
3
Cytogenetic studies in patients with mastocytosis.肥大细胞增多症患者的细胞遗传学研究。
Cancer Genet Cytogenet. 2000 Jul 15;120(2):131-5. doi: 10.1016/s0165-4608(99)00256-3.
4
Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.尿 11β-PGF2α 和 N-甲基组氨酸与肥大细胞疾病的骨髓活检结果相关。
Allergy. 2015 Oct;70(10):1230-8. doi: 10.1111/all.12668. Epub 2015 Jun 24.
5
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.系统性肥大细胞疾病的血液学表现:一项关于实验室检查、形态学特征及其与预后关系的前瞻性研究
Am J Med. 1991 Dec;91(6):612-24. doi: 10.1016/0002-9343(91)90214-i.
6
Effect of granulocyte macrophage colony-stimulating factor in a patient with benign systemic mastocytosis.粒细胞巨噬细胞集落刺激因子对一名良性系统性肥大细胞增多症患者的影响。
Br J Dermatol. 2001 Oct;145(4):661-6. doi: 10.1046/j.1365-2133.2001.04435.x.
7
A case of malignant mastocytosis with near-haploid, near-diploid, and polyploid cells in the bone marrow.1例骨髓中存在近单倍体、近二倍体和多倍体细胞的恶性肥大细胞增多症。
Cancer Genet Cytogenet. 1990 Aug 1;48(1):13-21. doi: 10.1016/0165-4608(90)90210-2.
8
A near-haploid bone marrow karyotype in systemic mast cell disease: is it characteristic of the disease or an incidental finding?系统性肥大细胞增多症中的近单倍体骨髓核型:这是该疾病的特征还是偶然发现?
Cancer Genet Cytogenet. 1998 Jun;103(2):124-9. doi: 10.1016/s0165-4608(97)00386-5.
9
An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.系统性肥大细胞增多症骨髓病变的免疫组织化学研究:病变肥大细胞干细胞因子的表达
Am J Clin Pathol. 2002 Aug;118(2):242-7. doi: 10.1309/71KH-4JE4-E0J1-7THH.
10
[Mastocytosis: when should it be considered?].[肥大细胞增多症:何时应考虑该病?]
Rev Med Suisse. 2009 Apr 15;5(199):837-42.